Cutera, Inc. (CUTR)
收市後：
| 前收市價 | 6.02 |
| 開市 | 6.04 |
| 買盤 | 5.36 x 800 |
| 賣出價 | 5.44 x 1300 |
| 今日波幅 | 5.21 - 6.14 |
| 52 週波幅 | 5.21 - 52.89 |
| 成交量 | |
| 平均成交量 | 772,144 |
| 市值 | 106.301M |
| Beta 值 (5 年，每月) | 1.65 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -3.77 |
| 業績公佈日 | 2023年11月01日 - 2023年11月06日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 23.00 |
BenzingaWhy Are Cutera Shares Diving Today?
Provider of aesthetic and dermatology solutions, Cutera Inc (NASDAQ: CUTR) shares are down after changes in executive leadership and the withdrawal of annual guidance. The company appointed Sheila Hopkins as Interim CEO and Janet D. Widmann as Independent Chair of the Board, effective immediately. The appointments of Ms. Hopkins and Ms. Widmann follow the immediate terminations of Daniel Plants as Executive Chairman and David Mowry as CEO for cause. The Board's search for a permanent CEO is unde
InvestorPlace7 Short-Squeeze Stocks That Could Explode in April
While an extremely risky proposition, short-squeeze stocks – as meme traders demonstrated – can occasionally yield radical profitability. However, you don’t want to just pick any beaten-down security as a possible comeback candidate. At the heart of the matter, a high magnitude of short interest translates to bearish sentiment, not bullish. Instead, prospective speculators may want to consider short-squeeze stocks that may appear to be bleeding out but also command positive fundamentals. Whether
BenzingaAnalyst Says Cutera's Recurring Revenue Model Tempered By Economic Overhang
William Blair has initiated coverage on Cutera Inc (NASDAQ: CUTR) with a Market Perform rating. The analyst writes that in a $13.9 billion aesthetics industry expected to grow at an 11% five-year compound annual rate, Cutera should take share with its redefined strategy centered on innovation and growing recurring revenue. Cutera's new AviClear device should drive over 50% of company growth in the next two years and represent a potential platform product for the company. Related: Macro Factors T
